We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GE Aerospace | NYSE:GE | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.15 | 0.71% | 162.41 | 163.365 | 160.3114 | 161.24 | 5,898,024 | 00:52:56 |
By Michael Dabaie
GE Healthcare said it received U.S. Food and Drug Administration 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems.
The healthcare business of General Electric Co. said this includes new features based on artificial intelligence that enable clinicians to acquire faster, more repeatable exams consistently.
"With the Vivid Ultra Edition, we offer AI capabilities that help address healthcare providers' two key challenges in echo exams--how time consuming the exam is and the degree of variability that exists in the quantitative results," said Dagfinn Saetre, general manager of cardiovascular ultrasound at GE Healthcare.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
October 12, 2020 08:26 ET (12:26 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year GE Aerospace Chart |
1 Month GE Aerospace Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions